Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma
about
Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.Clinicopathological correlation and prognostic significance of sonic hedgehog protein overexpression in human gastric cancerClinical and prognostic association of transcription factor SOX4 in gastric cancer.Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer.In situ carcinoma developed over oral lichen planus: a case report with analysis of BUB3, p16, p53, Ki67 and SOX4 expression.miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4.Upregulated Expression of SOX4 Is Associated with Tumor Growth and Metastasis in Nasopharyngeal Carcinoma.SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer.SOX4 Promotes Progression in OLP-Associated Squamous Cell Carcinoma.Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis.The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe?SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis.SOX4 promotes melanoma cell migration and invasion though the activation of the NF-κB signaling pathway.SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafishIncreased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.SOX4 expression is closely associated with differentiation and lymph node metastasis in oral squamous cell carcinoma.The expression of Nek7, FoxM1, and Plk1 in gallbladder cancer and their relationships to clinicopathologic features and survival.SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
P2860
Q33805874-E1268836-421B-42BA-B17B-F3E90A6A29B7Q34121564-FDF121D7-85E7-4CF5-A9C6-D79FD453F14CQ34534615-A56A4AAD-447F-4112-93B9-D3E302F318B3Q34796489-3C3D2B9C-1E5C-429B-9D1C-B4604A9DC643Q36029179-345C0F1B-CEFD-46C2-AAA8-77687BD6C3BFQ36138348-20FEE80A-457A-4886-9DCB-E386407EA414Q36249545-A239997C-869D-41B6-AEE1-6303E193B18EQ36349907-80118D67-AC5E-4A3D-83DE-8E462BAD7E96Q36990673-67C0E220-20F4-4FC1-B38D-D9A678AE6146Q37133681-A2889B48-79F9-4029-BB54-AF9E2FD65B7EQ38053346-7BE192A1-A9EC-497E-808C-F0669A247C0CQ38068040-CBFEF364-C1D0-455E-BFAA-966CD7E71168Q38562153-6B43B1F1-9F2C-40AB-A502-EE85EF4A8B87Q38719562-18B04C2B-4144-4236-8597-797A23583412Q40813966-63C93CC3-A23C-433D-B77A-974288FAA257Q41177054-6FA26201-3BEB-4817-9DED-E17AEFAA8A13Q41612074-28238430-2239-4CA0-9B33-37056CF2D96CQ43835062-A5B01726-2816-4729-ACAF-DD29CBD7504EQ53122558-95801CCD-0DBE-4B72-81D8-1F2D38E3AFA3Q53643055-8D32D78F-3570-4513-BA46-2A32F5B9D47E
P2860
Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma
@ast
Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma
@en
type
label
Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma
@ast
Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma
@en
prefLabel
Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma
@ast
Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma
@en
P2093
P2860
P356
P1433
P1476
Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma
@en
P2093
Chengguo Wang
Huadong Zhao
Jianguo Lu
P2860
P2888
P356
10.1186/1746-1596-7-41
P577
2012-04-17T00:00:00Z
P5875
P6179
1028323008